Nobivac DHP Live Vet. pulver og solvens til injektionsvæske, suspension
Nobivac DHP Live Vet. pulver og solvens til injektionsvæske, suspension
Authorised
- Canine adenovirus 2, strain Manhattan LPV3, Live
- Canine parvovirus, strain 154, Live
- Canine distemper virus, strain Onderstepoort, Live
- Canine adenovirus 2, strain Manhattan LPV3, Live
- Canine parvovirus, strain 154, Live
- Canine distemper virus, strain Onderstepoort, Live
Product identification
Medicine name:
Nobivac DHP Live Vet. pulver og solvens til injektionsvæske, suspension
Active substance:
- Canine adenovirus 2, strain Manhattan LPV3, Live
- Canine parvovirus, strain 154, Live
- Canine distemper virus, strain Onderstepoort, Live
- Canine adenovirus 2, strain Manhattan LPV3, Live
- Canine parvovirus, strain 154, Live
- Canine distemper virus, strain Onderstepoort, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine adenovirus 2, strain Manhattan LPV3, Live10000.00/50% tissue culture infectious dose1.00millilitre(s)
-
Canine parvovirus, strain 154, Live1000000.00/50% tissue culture infectious dose1.00millilitre(s)
-
Canine distemper virus, strain Onderstepoort, Live10000.00/50% tissue culture infectious dose1.00millilitre(s)
-
Canine adenovirus 2, strain Manhattan LPV3, Live10000.00/50% tissue culture infectious dose1.00millilitre(s)
-
Canine parvovirus, strain 154, Live1000000.00/50% tissue culture infectious dose1.00millilitre(s)
-
Canine distemper virus, strain Onderstepoort, Live10000.00/50% tissue culture infectious dose1.00millilitre(s)
Pharmaceutical form:
-
Powder and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AD02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Denmark
Available in:
-
Denmark
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Danish Medicines Agency
Authorisation number:
- 14110
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Danish (, PULVER OG SOLVENS TIL INJEKTIONSVÆSKE, SUSPENSION)
Published on: 14/03/2026